Clinical TrialID 6095
Anticholium® Per Se
NCT03013322
Shock, Septic|Sepsis|Perioperative Period
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6095
- Evidence Id
- 6095
- Core Evidence Id
- 6095
- Source Clinical Trial Id
- 6077
- Herb2 Clinical Trial Id
- HBCT006077
- Nct Id
- NCT03013322
- Title
- Anticholium® Per Se
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Shock, Septic|Sepsis|Perioperative Period
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Physostigmine|DRUG: Isotonic Saline
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Quadruple
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 20
- Outcome Measure
- mean Sequential Organ Failure Assessment (SOFA) score, The mean SOFA score (at least two individual values) during treatment and subsequent intensive care of up to 14 days is used as surrogate outcome in critically ill patients with perioperative sepsis and septic shock due to intra-abdominal infection., up to 14 d, assessed 2 h±30 min, 24±2 h, 48±2 h, 72±2 h, 96±2 h, 120±2 h, 6 d±4 h, 7 d±4 h, 8 d±8 h, 9 d±8 h, 10 d±8 h, 11 d±8 h, 12 d±8 h, 13 d±8 h, 14 d±8 h after continuous infusion is commenced
- Sponsor Collaborator
- University Hospital Heidelberg
- Funded By
- OTHER
- Location
- University Hospital Heidelberg, Heidelberg, Baden-Württemberg, 69120, Germany
- Other Id
- D.10060224
- Start Date
- 2015-01-28
- Primary Completion Date
- 2017-02-18
- Completion Date
- 2017-02-18
- First Posted
- 2017-01-06
- Results First Posted
- Last Update Posted
- 2018-01-29
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03013322
- Title Cn
- Title En
- Anticholium® Per Se
- Bilingual Status
- semi_complete